Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food and Rabeprazole Effect on HMPL-523 PK in Healthy Volunteers
NCT05571787Phase 1Completed
- Sponsor
- HUTCHMED
- Start
- Jul 2022
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of sovleplenib in lymphoma (4 arms), sponsored by HUTCHMED. Primary endpoints: Area Under the Concentration-time Curve from Time Zero to Last Quantifiable Concentration, Area Under the Concentration-time Curve from Time Zero to Infinity and 2 more. Started Jul 2022; status: completed.
02
Drugs
sovleplenib
03
Conditions
lymphoma
Beyond the preview
Go deeper on NCT05571787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05571787.